Relief Announces Notice of Annual General Meeting of RELIEF THERAPEUTICS Holding AG
EQS Group-News: RELIEF THERAPEUTICS Holdings AG
/ Key word(s): AGMEGM
27.05.2021 / 07:00
Geneva, Switzerland, May 27, 2021 - RELIEF THERAPEUTICS Holding AG (SIX: RLF, OTCQB: RLFTF) ("
Relief" or the "
Company"), a biopharmaceutical company with its lead compound RLF-100
TM (aviptadil) in advanced clinical development to treat severe COVID-19 patients, today gives notice of the Annual General Meeting (AGM) of shareholders to be held on June 18, 2021.
As a result of the exceptional circumstances due to the coronavirus pandemic, the AGM will be held without the physical presence of shareholders in accordance with article 27 of the Ordinance 3 on Measures to Combat the Coronavirus. Guidelines on how to deliver voting instructions can be found in the AGM formal invitation, which is being sent out today to registered shareholders.